UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K / A

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 24, 2013

 

 

DCP Holding Company

(Exact name of registrant as specified in its charter)

 

 

 

Ohio   0-51954   20-1291244
(State or other jurisdiction of   (Commission   (I.R.S. Employer
incorporation or organization)   File Number)   Identification No.)

 

100 Crowne Point Place, Sharonville, Ohio   45241
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (513) 554-1100

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On April 24, 2013, two new director nominees, Dr. Mark E. Bronson, DDS and Dr. Robert E. Hamilton, DDS, were elected to the Board of Directors of the Company at the 2013 Annual Meeting. On May 8, 2013, Dr. Mark Bronson and Dr. Robert Hamilton were both assigned to serve on the Company’s Corporate Affairs Committee and Clinical Affairs Committee by Dr. Stephen T. Schuler, DMD, Chairman of the Board of Directors. This decision was ratified by the Corporate Affairs Committee and the Board of Directors.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

        DCP Holding Company
    /s/ Robert C. Hodgkins, Jr.
Date: May 13, 2013     Robert C. Hodgkins, Jr.
    Vice President and Chief Financial Officer